BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Tilly's
TLYS
$123M
| $47.8K | ﹤0.01% |
4,296
+2,626
| +157% | +$31.1K |
|
3402
Alpha and Omega Semiconductor
AOSL
$936M
| $47.8K | ﹤0.01% |
4,152
+3,365
| +428% | +$37.2K |
|
3403
Southern Missouri Bancorp
SMBC
$852M
| $47.8K | ﹤0.01% |
1,551
+1,349
| +668% | +$46.4K |
|
|
RBNC
3404
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $47.7K | ﹤0.01% |
2,139
+1,843
| +623% | +$41K |
|
3405
KB Financial Group
KB
$41.9B
| $47.7K | ﹤0.01% |
1,287
+494
| +62% | +$19.7K |
|
3406
Hingham Institution for Saving
HIFS
$695M
| $47.6K | ﹤0.01% |
277
+251
| +965% | +$47.1K |
|
|
FTSV
3407
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $47.6K | ﹤0.01% |
+2,945
| New | +$46.7K |
|
3408
Regional Management Corp
RM
$301M
| $47.6K | ﹤0.01% |
1,948
+1,321
| +211% | +$35.2K |
|
|
RVI
3409
DELISTED
Retail Value Inc. Common Shares
RVI
| $47.5K | ﹤0.01% |
16,614
-9,042
| -35% | -$25.4K |
|
3410
i3 Verticals
IIIV
$316M
| $47.3K | ﹤0.01% |
1,968
+1,923
| +4,273% | +$44.7K |
|
3411
Quanterix
QTRX
$139M
| $47.3K | ﹤0.01% |
1,830
+1,799
| +5,803% | +$40.2K |
|
3412
Forte Biosciences
FBRX
$1.57B
| $47.3K | ﹤0.01% |
+12
| New | +$46.4K |
|
3413
Metropolitan Bank Holding Corp
MCB
$1.17B
| $47.2K | ﹤0.01% |
1,358
+1,142
| +529% | +$40.8K |
|
|
SBT
3414
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $47.2K | ﹤0.01% |
4,652
+4,204
| +938% | +$38.8K |
|
|
CWBC
3415
Community West Bancshares
CWBC
$705M
| $47.2K | ﹤0.01% |
2,412
+2,043
| +554% | +$40K |
|
|
NPTN
3416
DELISTED
NEOPHOTONICS CORP
NPTN
| $47.1K | ﹤0.01% |
7,485
+6,028
| +414% | +$42.2K |
|
3417
Village Super Market
VLGEA
$639M
| $47K | ﹤0.01% |
1,721
+1,310
| +319% | +$37.1K |
|
|
CTO
3418
CTO Realty Growth
CTO
$824M
| $47K | ﹤0.01% |
2,932
+2,615
| +825% | +$42.3K |
|
|
XRN
3419
Chiron Real Estate Inc
XRN
$486M
| $47K | ﹤0.01% |
956
+827
| +641% | +$40.8K |
|
3420
Lands' End
LE
$387M
| $46.9K | ﹤0.01% |
2,826
+2,592
| +1,108% | +$44.2K |
|
3421
Cytosorbents Corp
CTSO
$23.3M
| $46.9K | ﹤0.01% |
+6,193
| New | +$48.2K |
|
|
KZR
3422
DELISTED
Kezar Life Sciences
KZR
| $46.8K | ﹤0.01% |
+264
| New | +$52K |
|
|
CALA
3423
DELISTED
Calithera Biosciences, Inc
CALA
| $46.7K | ﹤0.01% |
347
+292
| +531% | +$30.7K |
|
3424
Clear Channel Outdoor Holdings
CCO
$1.2B
| $46.5K | ﹤0.01% |
8,694
+6,458
| +289% | +$34.7K |
|
|
PENG
3425
Penguin Solutions Inc
PENG
$3.22B
| $46.5K | ﹤0.01% |
+4,844
| New | +$62.7K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.